In vitro hematoporphyrin (Hpd) inhibitory effects on some immunological assays.

Hematoporphyrin derivative (Hpd) is a fluorescent dye that is preferentially incorporated by tissues with a high mitotic index, such as tumor cells and blast cells. A cytotoxic effect is produced following light activation. Previous studies have shown a long lasting reversible inhibition of DNA synthesis in Hpd-treated cells that failed to stimulate allogeneic lymphocytes in either primary or in secondary MLR. In this study we report Hpd inhibitory effects on some immunological assays in vitro. Treatment with Hpd of cytotoxic effector cells resulted in inhibition of their lytic activity likely dependent on the loss of binding to target cells. In the same way Hpd treatment inactivated the lytic activity of NK cells. In contrast Hpd-treatment of target cells did not modify the above immunological reactions. Moreover Con A agglutinability, antibody dependent capping as well as E-rosettes were inhibited following an Hpd treatment of relevant cells. Since normal susceptibility to humoral and cell mediated lysis was exhibited by Hpd-treated cells it is unlikely that cell surface molecules were damaged. An inhibitory effect exerted by an Hpd treatment on cell surface movements might explain these findings.

[1]  T J Dougherty,et al.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.

[2]  H. C. Robertson,et al.  Hematoporphyrin‐Derivative Fluorescence in Malignant Neoplasms , 1968, Journal of the South Carolina Medical Association.

[3]  A. Markenson,et al.  Impaired T-cell mitogen responses in some patients with thalassemia intermedia. , 1981, Thymus.

[4]  M. C. Berenbaum,et al.  Photodynamic destruction of human bladder carcinoma. , 1975, British Journal of Cancer.

[5]  B. Benacerraf,et al.  T-lymphocyte mediated cytolysis: temperature dependence of killer cell dependent and independent phases and lack of recovery from the lethal hit at low temperatures. , 1975, Cellular immunology.

[6]  J. Moan,et al.  Photodynamic inactivation of synchronized human cells in vitro in the presence of hematoporphyrin. , 1979, Cancer research.

[7]  C. Wilson,et al.  Photodynamic therapy of malignant tumours. , 1972, Lancet.

[8]  A. Goldin,et al.  Adoptive immunotherapy in BALB-c times DBA-2 Cr F1 mice bearing an immunogenic subline of L1210 leukemia. , 1974, Cancer research.

[9]  J. Winkelman,et al.  Quantitative determination of porphyrin uptake by tumor tissue following parenteral administration. , 1960, Bulletin of the Johns Hopkins Hospital.

[10]  E. Martz Early steps in specific tumor cell lysis by sensitized mouse T lymphocytes. I. Resolution and characterization. , 1975, Journal of immunology.

[11]  L Ricci,et al.  HAEMATOPORPHYRIN‐TREATED MURINE LYMPHOCYTES: IN VITRO INHIBITION OF DNA SYNTHESIS AND LIGHT‐MEDIATED INACTIVATION OF CELLS RESPONSIBLE FOR GVHR * , 1981, Photochemistry and photobiology.

[12]  J. Wunderlich,et al.  Qualitative and quantitative studies of cytotoxic immune cells. , 1971, Journal of immunology.

[13]  J E Kaufman,et al.  Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.

[14]  F. Figge,et al.  Cancer Detection and Therapy. Affinity of Neoplastic, Embryonic, and Traumatized Tissues for Porphyrins and Metalloporphyrins.∗ , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[15]  J. Cerottini,et al.  Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. , 1974, Advances in immunology.

[16]  D. Tripodi,et al.  Separation of peripheral leukocytes by Ficoll density gradient centrifugation. , 1971, Transplantation.

[17]  Denis R. Miller,et al.  Lymphoid Cell Sets and Serum Immunoglobulins in Patients with Thalassaemia Intermedia: Relationship to Serum Iron and Splenectomy , 1980, British journal of haematology.

[18]  A. Nicolin,et al.  Inhibition of Cellular DNA Synthesis and Lack of Antileukemic Activity by Non-Photoactivated Hematoporphyrin Derivative , 1981, Tumori.

[19]  F. Figge,et al.  Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin , 1955, Surgical forum.

[20]  A. M. Olsen,et al.  The use of a derivative of hematoporphyrin in tumor detection. , 1961 .